Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 234
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT07619833 | To Evaluate the Efficacy and Safety of Initial Combination Therapy With DWP16001 and DWC202518 Compared to DWP16001 Monotherapy and DWC202518 Monotherapy in Patients With Type 2 Diabetes Mellitus | ||
| NCT06119958 | Drug-drug Interactions Between DWC202313 and DWC202314 in Healthy Subjects | ||
| NCT04749173 | To Assess the Safety, Tolerability and Pharmacokinetic Properties of Niclosamide Injectable (DWRX2003) Which is the Treatment of COVID-19 in Healthy Volunteers. | ||
| NCT06036342 | Atrial Fibrillation Screening With MobiCARE in Subjects With Health Care Examination | ||
| NCT05868967 | A Clinical Study to Investigate the Mass Balance and Biotransformation of [14C]DWP14012 in Healthy Chinese Male Subjects | ||
| NCT04632862 | The Efficacy and Safety of DWP16001 Compared to Placebo in the Treatment of Type 2 Diabetes Mellitus. | ||
| NCT05812404 | Phase 1 Clinical Trial to Evaluate the Effect of DWP14012 on the Pharmacokinetics of DWC202201 in Healthy Subjects | ||
| NCT05660135 | Reduction Efficacy of OLOMAX for Blood Pressure and Low-density Lipoprotein Cholesterol in Hypertensive Patients With Dyslipidemia | ||
| NCT05414591 | Pharmacokinetics and Safety Following Administration of DWP16001 | ||
| NCT05737771 | To Compare the Pharmacokinetic Characteristics of the Fixed-dose Combination Compared to the Loose Combination | ||
| NCT03512821 | A Single-dose, Comparative Bioavailability Study of Two Formulations of Ursodiol 500mg Tablets Under Fed Conditions | ||
| NCT01493856 | A Clinical Trial to Compare the Safety and Pharmacokinetic Characteristics of Combination of Rosuvastatin and CS-866 and DWJ1276 | ||
| NCT04827472 | Study to Evaluate the Safety/Tolerability, Pharmacokinetics, and Pharmacodynamics After Intravenous DWJ1521 Administration in Healthy Adult Volunteers | ||
| NCT04613895 | Treatment Effect According to Timing of Administration of DWP14012 40 mg | ||
| NCT05505994 | The Efficacy and Safety of DWP16001 in Combination With Metformin in T2DM Patients Inadequately Controlled on Metformin | ||
| NCT02241850 | Genetic Polymorphisms Affecting Effect of High Intensity Training | ||
| NCT04888715 | To Evaluate Drug-drug Interactions Between DWN12088 and Pirfenidone or Nintedanib in Healthy Volunteers | ||
| NCT04477369 | Safety and Pharmacokinetics of DWJ1439, DWJ1464, DWC202003 or DWC202004 in Healthy Volunteers | ||
| NCT05083299 | Multicenter, Therapeutic Use Observational Study to Evaluate the Effects of Concurrent Therapy of Sarpogrelate | ||
| NCT05192395 | A Crossover Study of DWJ1525 to Evaluate the Safety and Pharmacokinetic Properties in Healthy Volunteers | ||
| NCT03224117 | Clinicial Trial to Evaluate the Efficacy and Safety of DWJ211 in Patient With Moderate or Severe Submental Fat | ||
| NCT03364985 | Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DWP16001 After Oral Administration in Healthy Male Volunteers | ||
| NCT06010589 | Bioequivalence Study for the Safety and the Pharmacokinetics of DWJ1558 in Healthy Adult Volunteers | ||
| NCT05149274 | Evaluate the Pharmacokinetics and Safety of DWP14012 Tablet A and Compare Those of DWP14012 Tablet B in Healthy Subjects | ||
| NCT02757144 | Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DWP14012 After Oral Administration in Healthy Male Volunteers | ||
| NCT03009487 | A Clinical Trial to Evaluate the Efficacy and Safety of Olmesartan/Amlodipine/Rosuvastatin Combination Treatment in Patients With Concomitant Hypertension and Hyperlipidemia | ||
| NCT05226533 | Clinical Trials to Assess Safety and Efficacy of DWRX2003 Combination With Remdesivir in Moderate to Severe COVID-19 Patients. | ||
| NCT07558707 | Fexuclue for Prevention of NSAIDs-Induced Peptic Ulcer in Real-World Practice | ||
| NCT01094847 | Clinical Trials to Compare Mosapride Bioavailability Between DWJ1252 and Mosapride Medicine | ||
| NCT02952755 | Drug-Drug Interaction Study Between DWC20155 / DWC20156 and DWC20162 in Healthy Volunteers | ||
| NCT05614778 | Study to Investigate the Efficacy and Safety After Administration of Daewoong Zoledronic Acid for the Purpose of Treatment or Prevention of Osteoporosis | ||
| NCT04120753 | Clinical Trial to Evaluate the Efficacy and Safety of OLOMAX Tab | ||
| NCT03184402 | Efficacy and Safety of DWJ1252 in the Treatment of Functional Dyspepsia (PART 2) | ||
| NCT01094834 | A Multiple Dose Study of DWP05195 in Healthy Adult Subjects | ||
| NCT06948487 | Efficacy and Safety of FEXUCLUE Tab. In Patients With Acute or Chronic Gastritis | ||
| NCT05926414 | To Evaluate the Efficacy and Safety of Envlo Tablet or Envlomet SR Tablet in Patients With Type II Diabetes Mellitus | ||
| NCT01552954 | Effects of Low Sodium Intake on the Anti-proteinuric Efficacy in Hypertensive Patient With Olmesartan | ||
| NCT06141980 | Study to Evaluate the Long Term Safety and Efficacy of DWP16001 in Patients With Type 2 Diabetes Mellitus | ||
| NCT05410535 | To Evaluate Efficacy of Ursodeoxycholic Acid (UDCA) for the Prevention of Gallstone Formation After Gasterectomy | ||
| NCT06682000 | Efficacy and Safety of DWC202404 and DWC202314 in Patients With Hypertension | ||
| NCT04634500 | The Efficacy and Safety of DWP16001 in Combination With Metformin in Patients With Type 2 Diabetes. | ||
| NCT02947620 | Metformin/Atorvastatin Combination Therapy in Subjects With Type II Diabetes and Dyslipidemia (Phase 3) | ||
| NCT07515599 | Observational Study to Evaluate the Efficacy of OLMETEC Tab on Nocturnal Blood Pressure Control in Patients With Stage Ⅰ Hypertension | ||
| NCT06606093 | Evaluate the Efficacy and Safety of DWP16001 in Type 2 Diabetic Nephropathy with Moderate Renal Impairment Patients | ||
| NCT05747664 | To Compare the Safety and PK/PD Characteristics of Subjects With Between Hepatic Impairment and Normal Hepatic Function | ||
| NCT07465549 | CART BP Pro-Guided Blood Pressure Management for Uncontrolled Hypertension | ||
| NCT01636401 | Efficacy and Safety of 400 μg Twice Daily of Aclidinium Bromide vs. Placebo When Administered to Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) | ||
| NCT05614765 | Evaluation of Dyslipidemia Management After Statin and Ezetimibe Complex Treatment | ||
| NCT02069717 | Observational Study to Assess the Incidence Rate of the Major Adverse Cardiovascular Events (MACE) and Safety of Fenofibrate (Lipilfen Capsule) | ||
| NCT05845489 | Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis- CloPidogREl for Primary preVENTION (HOST-PREVENTION) |
